RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
Até quando gastarão dinheiro e tempo com isto? Já deu, né?
Bah, cada vez mais provas que é somente ilusão
#Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infection, in a double-blind randomized placebo-controlled trial performed at 2 University of Pennsylvania hospitals https://t.co/PUqUeA0dnP
RT @mtrokko2: クロロキンはCOVID減らさない Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Ca…
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/2sKxFGf4Pn a través de @JAMAInternalMed part of @JAMANetwork
RT @mtrokko2: クロロキンはCOVID減らさない Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Ca…
RT @mtrokko2: クロロキンはCOVID減らさない Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Ca…
RT @mtrokko2: クロロキンはCOVID減らさない Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Ca…
クロロキンはCOVID減らさない Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/C8Jwbsx6JZ @JAMAInternalMed part of @JAMANetworkより
Toujours et encore...negatif https://t.co/7zHHnTmLQz
@Sebco47960604 @WaterTrue @Libre__Dz @raoult_didier •Abella (PATCH) https://t.co/KHH92IXlg8 •Barnabas https://t.co/XpSOKQ7jdZ •Mitja (BCN PEP-COV2) https://t.co/fhzGSS8wSy •Skipper (COVID-PEP) https://t.co/gsTjgffNMa •Self (ORCHID) https://t.co/MO
@streetbear57 Probably very little. It doesn't work, get over it https://t.co/5V08CGAqQF https://t.co/QtjMcxzQyV https://t.co/L94fD9DnNZ https://t.co/blUxYaWdeX
@bellanna @onyxlorenzoni Que estranho https://t.co/VMcFxmO1wV
@adriaandehaan @valecavazos @PerezArturo3 @lopezdoriga and that further studies with larger sample sizes could prove that it works. That does not mean that in this particular study HCQ works. Other evidence: https://t.co/SaHaSfuOxZ https://t.co/mhTz4CWby
@nessagagliardi @NeoRedPillBack @0Incorreto2 @oatila @ggmaultasch Chega desta mwrda porra https://t.co/gWWB1FKzhn
@PLarroque Boulware (COVID-19 PEP) https://t.co/65XVdis0j7 Ulrich https://t.co/Tl2DpiQQYL Abella (PATCH) https://t.co/AONChQGAS7 Barnabas https://t.co/xjzCUlGtMj Mitja (BCN PEP-COV2) https://t.co/XjPQTtckUS Skipper (COVID-PEP) https://t.co/lTvxd
@JanainaDoBrasil Esse outro artigo fala sobre os resultados positivos para uso de máscaras durante a pandemia. Mais uma vez, o PR demonstra pouco caso com o uso dessa proteção, pois anda circulando sem máscara. https://t.co/gxfrBKV1cQ
@JanainaDoBrasil Ñ sei se é má-fé, @JanainaDoBrasil.... mas vai alguns artigos sobre a falta de eficiência da hidroxicloroquina para COVID-19. E até ontem, PR pedia uso deste medicamento para como cuidados prevenção do COVID.
@RogerDouglas04 @lubertario @jobalberde @uolconfere Já saiu estudo randomizado com duplo cego mostrando ineficácia cara. Em revista com alto impacto no meio cientifico. Que é o tipo de teste necessário para provar eficácia de medicamento. Em nenhum do tipo
@Raul_path Mais um de PEP: https://t.co/MS5z5WK3XI
@Nichola37552193 @felipebottrel @LucianoSantosPM @CarlaZambelli38 @alexandregarcia Vou te demonstrar como não é simples dizer que é um fato que essa terapia funcione: https://t.co/5ND0qLoOVF https://t.co/QzvXXaeBav https://t.co/zyAij4xghu https://t.co/fSgR
@endireitando_b @TopFernando @Wilton1981 @em_com Pois este artigo refuta e é bem mais amplo. Pare de passar vergonha. https://t.co/NXTfYJEiXn
In this randomized clinical trial, although limited by early termination, there was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patients with COVID-19.https://t.co/0
RT @josegallucci: ❌ Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https…
❌ Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/XocgRMwZG8 via @JAMAInternalMed part of @JAMANetwork
@ThEpYrAttE @jc_Drop8 @fmomboisse @Delphine_D Il faudrait lire les études... https://t.co/JsOBVdfdu7
(JAMA Intern Med) Seguridad y eficacia de la hidroxicloroquina en la profilaxis preexposición del #SARSCoV2 en profesionales sanitarios https://t.co/5IDaBUtcYK ECA https://t.co/tEU7IT8zxj
@ClimateMalware @nationalpost "...reverse-transcriptase polymerase chain reaction–confirmed SARS-CoV-2 incidence between hydroxychloroquine and placebo cohorts." 2/2 https://t.co/HAWmQ7UPeY
@snorman1776 Unbelievably the one random placebo controlled trial of prophylaxis was terminated early because the felt it was not going to reveal any benefit. They subsequently admitted they might have missed a “modest” benefit. https://t.co/xwyZ8vVKLi htt
@HermanoBatalla @o_antagonista Segue mais um estudo mostrando que não funciona https://t.co/YXNX3dHNyE
@Misen_ @momotchiii @Etienne_Chouard Je n'ai pas parlé de preuve, cependant il existe une tendance dans les études qui en dit long: https://t.co/Aa4dItyAQL https://t.co/Lvsd94GGIT https://t.co/mnchc130tg https://t.co/BXHNsLRwyX https://t.co/2NkBjBIOVu
@akaBarni @tomselliott @RealSaavedra @AnandWrites But of course: https://t.co/Npyn3GDQu6
@Alodar @welshwoman17 @mil_ops How does this trial relate to your assertion? https://t.co/HchBq7hxL8
@Ussignur_ @cris_cersei @PaoloZoccoli Altro studio rct https://t.co/WXwHnqLCek ovviamente negativo sulla prep. la scienza funziona così. Osservazionali e retrospettivi servono per suggerire un’idea gli rct per confermala. L’idea era promettente ma non è st
@jcneall @ScottAdamsSays Don't give me an analytics of studies in a little picture... given me randomized blind studies - REAL SCIENCE. There are more of these. It does not work. https://t.co/uVFPWxkWLI
@ResetRedPill @linben63 @Reprobate24 https://t.co/qPSAnhej3S So of that 145 the first one I check says that there is no preventative effect when using HCQ (which is what Trump made popular by saying he'd take it himself) and side effects were noticable A
@crookeddy @syg80 @lu_bu_v @Birdyword Also: “In this RCT, although limited by early termination, there was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patients with
@PatriotMarine4 @shellipell @sarah_melv @DeanBrowningPA @CoryBooker You’re so full of shit. Big opinions with little knowledge. Some reading: https://t.co/1POWPPFOid https://t.co/Y7g7gvIXL0 https://t.co/zzSKP6mF1G https://t.co/4hBcNlTVA7 https://t
RT @ryoma_tanaka: 病院で勤務する医療従事者が、コロナウィルス感染予防のためにヒドロキシクロロキンを服用しても、効果はないっぽいです、という研究。 当初はかなりもてはやされましたが、治療でも予防でも、SARS-CoV-2関係でこの薬の名前を聞く機会は、めっきり…
RT @ryoma_tanaka: 病院で勤務する医療従事者が、コロナウィルス感染予防のためにヒドロキシクロロキンを服用しても、効果はないっぽいです、という研究。 当初はかなりもてはやされましたが、治療でも予防でも、SARS-CoV-2関係でこの薬の名前を聞く機会は、めっきり…
RT @ryoma_tanaka: 病院で勤務する医療従事者が、コロナウィルス感染予防のためにヒドロキシクロロキンを服用しても、効果はないっぽいです、という研究。 当初はかなりもてはやされましたが、治療でも予防でも、SARS-CoV-2関係でこの薬の名前を聞く機会は、めっきり…
RT @ryoma_tanaka: 病院で勤務する医療従事者が、コロナウィルス感染予防のためにヒドロキシクロロキンを服用しても、効果はないっぽいです、という研究。 当初はかなりもてはやされましたが、治療でも予防でも、SARS-CoV-2関係でこの薬の名前を聞く機会は、めっきり…
RT @ryoma_tanaka: 病院で勤務する医療従事者が、コロナウィルス感染予防のためにヒドロキシクロロキンを服用しても、効果はないっぽいです、という研究。 当初はかなりもてはやされましたが、治療でも予防でも、SARS-CoV-2関係でこの薬の名前を聞く機会は、めっきり…
RT @ryoma_tanaka: 病院で勤務する医療従事者が、コロナウィルス感染予防のためにヒドロキシクロロキンを服用しても、効果はないっぽいです、という研究。 当初はかなりもてはやされましたが、治療でも予防でも、SARS-CoV-2関係でこの薬の名前を聞く機会は、めっきり…
RT @ryoma_tanaka: 病院で勤務する医療従事者が、コロナウィルス感染予防のためにヒドロキシクロロキンを服用しても、効果はないっぽいです、という研究。 当初はかなりもてはやされましたが、治療でも予防でも、SARS-CoV-2関係でこの薬の名前を聞く機会は、めっきり…
@CharlotteTisch @ashishkjha @SenateHomeland @isabellesmullen @DavidHelfer21 The attack on science is astounding... To anyone in this thread that still believes that HCQ can prevent or treat COVID-19, please do your research. To start, here's a @JAMAIntern
@therecount um, as the first author of one of the published RCTs on hydroxychloroquine, I can personally tell you that the evidence of it working for COVID19 prevention or treatment is.... not there. https://t.co/KXBOYeXv7x
@ReasonCritical @ThierryMoine2 @wef @Ipsos https://t.co/vpQdt7fPB8 double blind study shows it didnt work to stop the spread either.
RT @BenjaminAbella: First published pre-exposure prophylaxis for #COVID19 using #hydroxychloroquine now published in @JAMAInternalMed - tha…
New2Trip: Efficacy & Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: Randomized Clinical Trial https://t.co/1AbTab4O39
RT @carpe_diem0820: HCQの曝露前投与はプラセボと比較して、COVID-19 HRが、週1回投与群で0.72(95%CI 0.44~1.16、P=0.18)、週2回投与群で0.74(95%CI 0.46~1.19、P=0.22) 有意差無 Hydroxych…
@suomicitizen @realDonaldTrump In this randomized clinical trial, although limited by early termination, there was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patien
@gvandervoet @pjvanerp @jangajentaan ..maar ook daarin wordt weer de noodzaak aangegeven van verder wetenschappelijk onderzoek. Er zijn juist ook meerdere andere onderzoeken geweest die geen resultaat toonden of juist extra risico's voor de gezondheid. 2/2
RT @tripdatabase: New2Trip: Efficacy & Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Wo…
New2Trip: Efficacy & Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: Randomized Clinical Trial https://t.co/1AbTab4O39
@tonyagunn7 @sburke85 @chrislhayes Try this study https://t.co/KSN8vx2sWM
@stevy_bell @ClaireJardin1 Puisque t'en es à balancer des études que tu ne comprends pas en voilà d'autres (spoiler, l'HCQ ca marche pas, avec AZT la mortalité AUGMENTE) : https://t.co/oIClrWtjwz https://t.co/b4G6TdS0q9 https://t.co/f1mfFmdCGk
@AJacquestupa @AdolfoL45424085 @JovemPanNews Rapidamente joguei no Google e achei esse estudo... tem vários mostrando a segurança... https://t.co/cfNiIkTA3h
New2Trip: Efficacy & Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: Randomized Clinical Trial https://t.co/1AbTab4O39
RT @DrEkstrom: Hydroxyklorokin skyddar inte mot infektion med #SARSCoV2. #svmed #covid19 #coronavirussverige https://t.co/TXAt6wLCig via @…
Hydroxyklorokin skyddar inte mot infektion med #SARSCoV2. #svmed #covid19 #coronavirussverige https://t.co/TXAt6wLCig via @JAMAInternalMed part of @JAMANetwork
@GerardAraud En support à votre argument M. Araud, un lien JAMA vers une étude (de plus) "There was no significant difference in infection rates in participants randomized to receive hydroxychloroquine compared with placebo" . M @YvesPDB vos propos sont m
@W4k3up_ @vtc123 @Moon32535996 @PeteButtigieg https://t.co/WymmKGmppP This is how the actual science looks like. If you have any critique of this article please feel free to share
@Woodynist @barledur @Claudius155 @olivierveran En quoi cet article avance une preuve d'efficacité de l'HCQ en prophylaxie ? De mon côté en faisant des recherches sur ce type d'utilisation, je tombe par ex sur ce RCT : https://t.co/tczYylbxxX Difficile d'i
@antoniod1979 eu digitei efeito placebo, não que é um. No mais: https://t.co/wLMJXkZTvR
@kccummins2 @ICNIC_L @CramerBryan @gummibear737 @tampabaymyhome Many double-blind RCT's show no benefit of hydroxychloroquine for COVID-19: https://t.co/zjPoJjxRHE, https://t.co/zXdzeHbbN9, , https://t.co/EwT9mzsNBG